HAC (Russian)
RSCI (Russian)
EBSCO
DOI (USA)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

ROLE OF [-2]proPSA AND ITS DERIVATIVES IN PROSTATE CANCER SCREENING IN MEN WITH A TOTAL PROSTATE-SPECIFIC ANTIGEN LEVEL OF 2-10 NG/ML

Download full text PDF
Issue: 
6
Year: 
2016

E. Nevirovich (1), Candidate of Medical Sciences; A. Yakovenko (1), Candidate of Medical Sciences; Professor A. Rumyantsev (1), MD; A. Selivanov (2), Candidate of Medical Sciences; S. Budylev (2), Candidate of Medical Sciences 1 -Acad. I.P. Pavlov First Saint Petersburg State Medical University 2 -City Hospital Thirty-One, Saint Petersburg

The efficiency of using [-2]proPSA and its derivative a p2PSA to free prostatespecific antigen (PSA) ratio (%p2PSA) for the early detection of prostate cancer in men with a total prostate-specific antigen level of 2 to 10 ng/ml.

Keywords: 
oncology
prostate cancer
[-2]proPSA
screening



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Alekseev S.M., Proschaev K.I., Il'nitskij A.N. i dr. Potentsial'noe vlijanie starcheskoj astenii na risk vozniknovenija oslozhnenij himiotera-pii u pozhilyh bol'nyh // Sovremennye problemy nauki i obrazovanija. – 2014; 3: URL: www.science-education.ru/117-13193
  2. Chissov V.I., Rusakov I.G. Zabolevaemost' rakom predstatel'noj zhele zy v Rossijskoj Federatsii // Eksperim. i klin. urol. – 2011; 2–3: 6–7.
  3. Schroder F., Hugosson J., Roobol M. et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up // Lancet. – 2014; 384 (9959): 2027–35.
  4. Mikolajczyk S., Marker K., Millar L. et al. A truncated precursor form of 4. prostate-specific antigen is a more specific serum marker of prostate cancer // Cancer Res. – 2001; 61 (18): 6958–63.
  5. Jansen F., Roobol M., Jenster G. et al. Screening for prostate cancer in 2008 5. II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins // Eur. Urol. – 2009; 55 (3): 563–74.